IL133863A0 - Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis - Google Patents

Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis

Info

Publication number
IL133863A0
IL133863A0 IL13386398A IL13386398A IL133863A0 IL 133863 A0 IL133863 A0 IL 133863A0 IL 13386398 A IL13386398 A IL 13386398A IL 13386398 A IL13386398 A IL 13386398A IL 133863 A0 IL133863 A0 IL 133863A0
Authority
IL
Israel
Prior art keywords
drugs
acid derivatives
removal promotion
pain remission
urinary lithiasis
Prior art date
Application number
IL13386398A
Other languages
English (en)
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of IL133863A0 publication Critical patent/IL133863A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13386398A 1997-07-25 1998-07-15 Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis IL133863A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23323997 1997-07-25
PCT/JP1998/003163 WO1999005090A1 (fr) 1997-07-25 1998-07-15 Derives d'acide aminoethylphenoxyacetique et medicaments qui reduisent la douleur et favorisent la suppression des calculs dans la lithiase urinaire

Publications (1)

Publication Number Publication Date
IL133863A0 true IL133863A0 (en) 2001-04-30

Family

ID=16951956

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13386398A IL133863A0 (en) 1997-07-25 1998-07-15 Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis

Country Status (29)

Country Link
US (1) US6399660B1 (de)
EP (1) EP1002791B1 (de)
JP (1) JP4002391B2 (de)
KR (1) KR100545473B1 (de)
CN (1) CN1137877C (de)
AR (1) AR013241A1 (de)
AT (1) ATE280146T1 (de)
AU (1) AU754579B2 (de)
BR (1) BR9811483B1 (de)
CA (1) CA2298493C (de)
CO (1) CO4970779A1 (de)
CZ (1) CZ300389B6 (de)
DE (1) DE69827137T2 (de)
ES (1) ES2231996T3 (de)
HK (1) HK1028016A1 (de)
HU (1) HUP0004055A3 (de)
ID (1) ID24062A (de)
IL (1) IL133863A0 (de)
MY (1) MY126743A (de)
NO (1) NO315422B1 (de)
NZ (1) NZ502366A (de)
PE (1) PE99899A1 (de)
PL (1) PL191864B1 (de)
PT (1) PT1002791E (de)
RU (1) RU2196130C2 (de)
SA (1) SA98190661B1 (de)
TW (1) TW418184B (de)
WO (1) WO1999005090A1 (de)
ZA (1) ZA986580B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69919860T2 (de) 1998-04-14 2005-08-25 Kissei Pharmaceutical Co., Ltd., Matsumoto 2-methylpropionsäure-derivate und sie enthaltende medizinische zubereitungen
MY126489A (en) * 1998-07-08 2006-10-31 Kissei Pharmaceutical Phenoxyacetic acid derivatives and medicinal compositions containing the same
RU2237656C2 (ru) * 1999-01-21 2004-10-10 Киссеи Фармасьютикал Ко., Лтд. Кристаллический полиморф 2-[4-[2-[[(1s,2r)-2-гидрокси-2-(4-гидроксифенил)-1- метилэтил]амино]этил]фенокси]уксусной кислоты
JP4532119B2 (ja) * 2002-03-22 2010-08-25 キッセイ薬品工業株式会社 腎疾患の予防又は治療剤
EP1424079A1 (de) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Kombination eines beta-3-Rezeptoragonisten und eines Serotonin und/oder Norepinephrin-Wiederaufnahmeinhibitors
DE10333569A1 (de) * 2003-07-23 2005-02-17 Z & J Technologies Gmbh Einrichtung zur Verteilung von Schüttgut in wenigstens zwei oberhalb der Gicht eines Hochofens angeordnete Bunker
WO2005077355A1 (ja) * 2004-02-12 2005-08-25 Kissei Pharmaceutical Co., Ltd. 食道の運動障害を伴う疾患の予防または治療用医薬組成物
WO2007004639A1 (ja) * 2005-07-06 2007-01-11 Daiichi Fine Chemical Co., Ltd. 光学活性エリスロ-β-アミノアルコールの製法
BRPI0615339A2 (pt) * 2005-08-29 2011-05-17 Kissei Pharmaceutical Combinação farmacêutica para a prevenção ou tratamento de doenças associadas com a diminuição de lágrimas
EP1769792A1 (de) * 2005-09-30 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co.KG Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden
ES2302447B1 (es) * 2006-10-20 2009-06-12 Laboratorios Almirall S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338333A (en) * 1979-06-16 1982-07-06 Beecham Group Limited Ethanamine derivatives their preparation and use in pharmaceutical compositions
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
ES2195021T3 (es) * 1995-11-30 2003-12-01 Kissei Pharmaceutical Medicamento para aliviar el dolor y favorecer la eliminacion de calculos en la urolitiasis.
WO1998013333A1 (fr) * 1996-09-26 1998-04-02 Kissei Pharmaceutical Co., Ltd. Derives de 2-amino-1-(4-hydroxy-2-methylphenyl)propanol

Also Published As

Publication number Publication date
CZ2000272A3 (cs) 2000-05-17
TW418184B (en) 2001-01-11
CA2298493A1 (en) 1999-02-04
US6399660B1 (en) 2002-06-04
PE99899A1 (es) 1999-11-11
CN1265091A (zh) 2000-08-30
MY126743A (en) 2006-10-31
AU8241998A (en) 1999-02-16
ID24062A (id) 2000-07-06
EP1002791A1 (de) 2000-05-24
NO20000371D0 (no) 2000-01-25
EP1002791B1 (de) 2004-10-20
EP1002791A4 (de) 2001-09-12
HUP0004055A3 (en) 2001-10-29
HUP0004055A2 (hu) 2001-04-28
NZ502366A (en) 2004-12-24
PT1002791E (pt) 2005-01-31
DE69827137D1 (de) 2004-11-25
JP4002391B2 (ja) 2007-10-31
ES2231996T3 (es) 2005-05-16
CZ300389B6 (cs) 2009-05-06
ATE280146T1 (de) 2004-11-15
NO315422B1 (no) 2003-09-01
DE69827137T2 (de) 2006-03-09
CN1137877C (zh) 2004-02-11
BR9811483A (pt) 2000-09-19
PL338234A1 (en) 2000-10-09
ZA986580B (en) 1999-02-04
KR100545473B1 (ko) 2006-01-24
CA2298493C (en) 2008-03-18
PL191864B1 (pl) 2006-07-31
NO20000371L (no) 2000-01-25
BR9811483B1 (pt) 2009-01-13
RU2196130C2 (ru) 2003-01-10
WO1999005090A1 (fr) 1999-02-04
HK1028016A1 (en) 2001-02-02
AU754579B2 (en) 2002-11-21
KR20010022124A (ko) 2001-03-15
CO4970779A1 (es) 2000-11-07
SA98190661B1 (ar) 2006-09-09
AR013241A1 (es) 2000-12-13

Similar Documents

Publication Publication Date Title
ZA9610935B (en) Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
PL307463A1 (en) Pharmaceutical agent especially for inhibiting osteoporosis and lowering cholesterol level in blood serum
EP1024130A4 (de) Biphenyl-5-alkansäure-derivate und ihre anwendung
HK1029914A1 (en) Device and pharmaceutical agent for treatment of dysmenorrhea
HUP0001286A3 (en) Pharmaceutical composition containing carbazole acetic acid for treating pain and inflammation in dogs
IL128600A0 (en) Propionic acid derivatives and pharmaceutical compositions containing them
EP1021175A4 (de) Verbindungen und verfahren zur therapeutischen intervention in diabetische komplikationsvorbeugung
HUP9902451A3 (en) Process and device for promotion of regeneration of organized tissues
IL133863A0 (en) Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis
HUP0100597A3 (en) Hydroxamic and carboxylic acid derivatives
AU6157899A (en) Catheter flush solution and method for its use
IL131666A0 (en) Novel carboxylic acid derivatives their preparation and use in treating cancer
HUP0004510A3 (en) Process for obtaining l-dihydroorotic acid and use thereof
GB9911071D0 (en) Hydroxamic and carboxylic acid derivatives
HUP0102073A3 (en) Hydroxamic and carboxylic acid derivatives and medicaments containing them
GB9911075D0 (en) HYdroxamic and carboxylic acid derivatives
GB9911073D0 (en) Hydroxamic and carboxylic acid derivatives
AU5319400A (en) Molecules for disease detection and treatment
AU2713797A (en) Depigmentating agent in the treatment of melasma
AU8236298A (en) Use of a humic acid-containing substance in medicine
AU5457300A (en) Surface stabilized microbubbles for use in ultrasound contrast and drug deliveryagents
EP1173185A4 (de) Medikament zur verbesserung der fruchtbarkeit und der fötalen entwicklung
GB9819572D0 (en) Hydroxamic and carboxylic acid derivatives
GB9819570D0 (en) Hydroxamic and carboxylic acid derivatives
GB9813932D0 (en) Hydroxamic and carboxylic acid derivatives

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees